title: Studies on smaller (approximately 315 microM) microcapsules: IV. Feasibility and safety of intrahepatic implantations of small alginate poly-L-lysine microcapsules.
abstract: The most successful transplantation site of nonencapsulated islets of Langerhans is the liver. Because usual alginate poly-L-lysine microcapsules were too large (700-1200 microm diameter) for intravascular implantations and were almost exclusively implanted intraperitoneally, the question of the preferred implantation site of microencapsulated islets has received little attention. The feasibility of implanting smaller (approximately 315 microm) alginate poly-L-lysine microcapsules into the liver and the effect of such implantations on portal pressure and liver histology was evaluated in Wistar rats. A bolus of 10,000 microcapsules of 315 microm diameter was injected intraportally (group 1; n = 22). The portal pressure increased from 6.4 +/- 1.8 mmHg to a maximum of 19 mmHg, returned to basal levels within 2 h, and remained normal after 2 months. In group 2 (n = 3), following the injection of 10,000 larger microcapsules (420 microm), the portal pressure increased to > 60 mmHg and two out of the three rats died within 3 h. When 5,000 microcapsules of 420-microm diameter were injected (group 3; n = 5), the portal pressure peaked to 30 +/- 8 mmHg and remained elevated after 4 h (12 +/- 3 mmHg), but returned to normal (8 +/- 1 mmHg) after 2 weeks. Histological studies showed normal hepatic architecture without collagen deposition into portal tracts occupied by microcapsules.
  
  
  CONCLUSIONS
  intrahepatic implantations of approximately 315-microm alginate poly-L-lysine microcapsules are feasible and safe. These results justify further investigation of this potential implantation site for microencapsulated islets.
authors.affiliation: Centre de Recherche Guy-Bernier, Hôpital Maisonneuve Rosemont, Université de Montréal, Québec, Canada.
authors.forename: F A
authors.initials: FA
authors.lastname: Leblond
authors.forename: G
authors.initials: G
authors.lastname: Simard
authors.forename: N
authors.initials: N
authors.lastname: Henley
authors.forename: B
authors.initials: B
authors.lastname: Rocheleau
authors.forename: P M
authors.initials: PM
authors.lastname: Huet
authors.forename: J P
authors.initials: JP
authors.lastname: Hallé
mesh_terms: D000464:Alginates; D000818:Animals; D002214:Capsules; D007840:Latex; D008099:Liver / Q000098:blood supply / Q000166:cytology; D008567:Membranes, Artificial; D008863:Microspheres; D011107:Polylysine / Q000031:analogs & derivatives*; D017082:Portal Pressure; D019736:Prostheses and Implants; D051381:Rats; D017208:Rats, Wistar; D013324:Strontium
chemical_list: D000464:Alginates; D002214:Capsules; D007840:Latex; D008567:Membranes, Artificial; C051546:alginate-polylysine-alginate; D011107:Polylysine; D013324:Strontium